- Home
- ACNT vs CLLS Comparison
ACNT vs CLLS Comparison
Compare ACNT & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNT
- CLLS
- Stock Information
- Founded
- ACNT 1945
- CLLS 1999
- Country
- ACNT United States
- CLLS France
- Employees
- ACNT N/A
- CLLS N/A
- Industry
- ACNT Steel/Iron Ore
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- ACNT Industrials
- CLLS Health Care
- Exchange
- ACNT Nasdaq
- CLLS Nasdaq
- Market Cap
- ACNT 128.3M
- CLLS 148.1M
- IPO Year
- ACNT N/A
- CLLS 2007
- Fundamental
- Price
- ACNT $12.81
- CLLS $1.30
- Analyst Decision
- ACNT
- CLLS Buy
- Analyst Count
- ACNT 0
- CLLS 3
- Target Price
- ACNT N/A
- CLLS $7.00
- AVG Volume (30 Days)
- ACNT 43.1K
- CLLS 836.8K
- Earning Date
- ACNT 03-04-2025
- CLLS 03-13-2025
- Dividend Yield
- ACNT N/A
- CLLS N/A
- EPS Growth
- ACNT N/A
- CLLS N/A
- EPS
- ACNT N/A
- CLLS N/A
- Revenue
- ACNT $177,872,000.00
- CLLS $49,217,000.00
- Revenue This Year
- ACNT $22.72
- CLLS $1.26
- Revenue Next Year
- ACNT N/A
- CLLS N/A
- P/E Ratio
- ACNT N/A
- CLLS N/A
- Revenue Growth
- ACNT N/A
- CLLS 435.38
- 52 Week Low
- ACNT $8.16
- CLLS $1.14
- 52 Week High
- ACNT $13.13
- CLLS $3.38
- Technical
- Relative Strength Index (RSI)
- ACNT 63.80
- CLLS 40.11
- Support Level
- ACNT $12.47
- CLLS $1.16
- Resistance Level
- ACNT $12.97
- CLLS $1.35
- Average True Range (ATR)
- ACNT 0.39
- CLLS 0.07
- MACD
- ACNT -0.02
- CLLS 0.01
- Stochastic Oscillator
- ACNT 67.26
- CLLS 42.31
About ACNT Ascent Industries Co.
Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.